Imricor Medical Systems, Inc. · ASX:IMR

Imricor Medical Systems — Investor Presentation (August 2022)

12 slides from Imricor Medical Systems's investor presentation, Aug 18, 2022

  1. Slide 1: Introduction

    For personal use only Introduction August 2022 IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) WWW.IMRICOR.COM

  2. Slide 2: Disclaimer

    Disclaimer For personal use only The material contained in this presentation is intended to be general background those which we expect, depending on the outcome of various factors. Investors and others information on Imricor Medical Systems, Inc. (Imricor) and its activities. are cautioned not to p

  3. Slide 3: Introduction to Imricor

    For personal use only Introduction to Imricor

  4. Slide 4: Cardiac ablation in conventional x-ray EP lab

    Cardiac ablation in conventional x-ray EP lab For personal use only INTRODUCTION | 4

  5. Slide 5: Cardiac ablation in an iCMR EP lab

    Cardiac ablation in an iCMR EP lab (iCMR: interventional cardiac magnetic resonance) For personal use only INTRODUCTION | 5

  6. Slide 6: Transitioning cardiac ablation into a new kind of lab

    Transitioning cardiac ablation into a new kind of lab Conventional x-ray EP lab iCMR EP lab (interventional cardiac magnetic resonance) For personal use only X-ray to iCMR Everyone else Only Imricor INTRODUCTION | 6

  7. Slide 7: Transitioning cardiac ablation into a new kind of lab

    Transitioning cardiac ablation into a new kind of lab Conventional x-ray EP lab iCMR EP lab (interventional cardiac magnetic resonance) For personal use only X-ray to iCMR Everyone else Only Imricor Enabled by Imricor’s MRI-compatible devices INTRODUCTION | 7

  8. Slide 8: Transitioning cardiac ablation into a new kind of lab

    Transitioning cardiac ablation into a new kind of lab Conventional x-ray EP lab iCMR EP lab (interventional cardiac magnetic resonance) For personal use only X-ray to iCMR Everyone else Only Imricor Physicians, Patients, Hospitals Imricor • Same kinds of tools, same procedures • Imricor captures 100

  9. Slide 9: A strong and growing market in cardiac ablation

    A strong and growing market in cardiac ablation For personal use only Drivers of Global Catheter Cardiac Ablation Disposables Market: Ablation Market US, EU, ANZ CATHETER SALES (USD M) $9,000.00 Increased incidence of cardiac disease $8,000.00 R $7,000.00 . 2 % CAG 8 $6,000.00 Shift towards $5,000.0

  10. Slide 10: Path to significant scale

    Path to significant scale For personal use only Growing with Expanding Addressing Today new Geographies Entire Market Indications iCMR Atrial Flutter iCMR Ventricular Tachycardia FDA approval in US Atrial Fibrillation Ablations (AFL) in the EU Ablations (VT) in the EU Ablations (Afib) worldwide • Ap

  11. Slide 11: Status and high-level plans

    Status and high-level plans For personal use only Re-launched products post pandemic Bring current sites online, performing procedures Initiate VT clinical trial Launch VT products (post approval) Add more sites Add more sites Q2 ‘22 Q3 ‘22 Q4 ‘22 2023 2024 2025+ Apply for approval to begin Complete

  12. Slide 12: Questions

    For personal use only Questions

Imricor Medical Systems — Investor Presentation (August 2022) on 6ix